Importantly, we demonstrated that the administration of an anti-YAPer-ORF-specific neutralizing antibody effectively inhibited YAP activity and suppressed tumor growth mediated by YAPer-ORF in an animal model. This evidence concerns the gene YAP1 and neoplasm.